Update : August 22, 2008    
Left main coronary
disease
Ostial disease
Bifurcation
Graft vessel disease
Diffuse coronary
disease
Chronic total
occlusion (CTO)
Restenosis
Multivessel disease
Drug eluting stent
Vulnerable plaque
Angioplasty Summit 2005 : Program

»»Thursday, April 28--»» Friday, April 29--»» Saturday, April 30
»» Moderated Poster Abstract Sesssion--
»» Live Case Operators

Thursday | April 28, 2005

Main Arena
Vista Hall, W-Hotel, Level B2
1:00 PM~6:30 PM

1:00 PM Welcome Address Seung-Yun Cho, MD
Chairman, The Korean Society of Circulation
Angioplasty Summit 2005-TCT Asia Pacific Introduction
1:10 PM Launching of The Joint Conference - Angioplasty Summit and TCT: Significance and Future Perspectives Seung-Jung Park, MD
1:20 PM TCT Asia Pacific: Where We Are Going... Martin B. Leon, MD
 
TCT Asia Pacific
Drug Eluting Stent Summit-I
Moderators: Martin B. Leon, MD, Seung-Jung Park, MD
1:30 PM Are All Sirolimus Analogs Alike? Robert Falotico, MD
1:45 PM New Drug Eluting Stents Alexandre Abizaid, MD
2:00 PM Is the TAXUS Stent Benefit Extended to the Most Complicated Patients and Lesions? Eberhard Grube, MD
2:15 PM The Perspective of Drug Eluting Stent in the Future
Martin B. Leon, MD
2:30 PM Late Loss Remains the Best Single Indicator of DES Performance! Richard E. Kuntz , MD
2:45 PM The "Appropriate" Use of IVUS During DES Procedures Gary S. Mintz, MD
3:00 PM DES Pathobiology Considerations: What We Know and What We Don't Know Can Hurt Us! Renu Virmani, MD
  The Great Debate:  
3:15 PM Why TAXUS Is Better ? Gregg W. Stone, MD
3:30 PM Why CYPHER Is Better ? Martin B. Leon, MD
     
3:45 PM Coffee Break
   
New Clinical Trials Updates 2005 - from TCT, AHA, ACC
Moderators: Gregg W. Stone,MD, Gary S. Mintz, MD
4:00 PM Recent Updates from the Taxus Trials (Taxus 2 and 4 Late FU, Taxus Meta-Analysis, and Taxus 5) Gregg W. Stone, MD
4:15 PM Recent Updates from the Cypher Trials (Cypher Meta-Analysis, Diabetes, Late FU from FIM and SIRIUS, ARTS II) Alexandre Abizaid, MD
4:30 PM A Critical Appraisal of the "Head-to-Head" Cypher vs. Taxus Trials Martin B. Leon, MD
4:45 PM The Endeavor DES Program (Focus on Endeavor 2) Richard E. Kuntz, MD
5:00 PM The Biolimus A9 DES Program (Focus on Stealth 1) Eberhard Grube, MD
5:15 PM Discussion  
   
Live Case Session 1
Asan Medical Center, Seoul, Korea : Cases #1, #2
Moderators: Gregg W. Stone, MD, Alan C. Yeung, MD
5:30 PM
Discussants:
Alexandre Abizaid, MD
Charles Chan, MD
Eberhard Grube, MD
Yang-Soo Jang, MD
Takeshi Kimura, MD
Richard E. Kuntz, MD
Ki Bae Seung, MD
Seung-Jea Tahk, MD
     
6:30 PM Adjourn  
 
Evening Symposia
Sheraton Grande Walkerhill Seoul Hotel
6:30 PM-8:30 PM
#1. The Future of DES and Complex PCI
Mugunghwa Room 1, Level 1
Sponsored by Boston Scientific Korea Co., Ltd.
Moderators: Gregg W. Stone, MD, Seong-Wook Park, MD
6:30 PM Buffet Dinner  
     
7:00 PM Opening Remark  
7:10 PM Taxus V Clinical Update Gregg W. Stone, MD
7:30 PM Diabetic Performance in Taxus Myung-Ho Jeong, MD
7:50 PM IVUS in Complex PCI Alan C. Yeung, MD
8:10 PM Pre & Post-Dilatation Strategies for DES Ted Feldman, MD
8:30 PM Panel Discussion  
   
#2. Virtual Histology; Beyond IVUS
Mugunghwa Room 2, Level 1
Sponsored by DAEIL CO., LTD
Moderators: Gary S. Mintz, MD, James R. Margolis, MD
6:30 PM Buffet Dinner  
     
7:00 PM Opening Remark  
7:10 PM Virtual History: Concept and Validation D. Geoffrey Vince, MD
7:30 PM Virtual Histology- A Technical & Clinical Update Gary S. Mintz, MD
7:50 PM Real World Paradigm for Identifying Vulnerable Plaques and Vulnerable Patients James R. Margolis, MD
8:10 PM Q & A  
   
#3. "ENDEAVOR"- What's New ? What's Different ?
Cosmos Room, Level 3
Sponsored by Medtronic Korea co., Ltd
Moderators: Richard E. Kuntz, MD, Ian T. Meredith, MD
6:30 PM Buffet Dinner  
     
7:00 PM Opening Remarks, MKL Top Management
Joon Hurh
7:05 PM Overview of Endeavor II Clinical Results Ian T. Meredith, MD
7:20 PM Safety and Endeavor II Subsets Richard E. Kuntz, MD
7:40 PM Endeavor II in Perspective Martin B. Leon, MD
8:00 PM Endeavor Q & A
Panelists :
In-Ho Chae, MD
Charles Chan, MD
Myeong-Ki Hong, MD
Richard E. Kuntz, MD
Ian T. Meredith, MD
John Ormiston, MD
Mohd Ali Rosli, MD
Ki Bae Seung, MD
Robaayah Zambahari, MD
   
#4. Is Cypher the Best Choice? - Clinical Perspectives of Cypher
Art Room, Level 4
Sponsored by Johnson & Johnson Medical Korea Ltd.
Moderators: Martin B. Leon, MD, Seung-Jung Park, MD
6:30 PM Buffet Dinner  
     
7:00 PM Opening Remark  
7:10 PM Body of Evidence - SIRTAX, ISAR-DIABETES, ISAR-DESIRE, ARTS II Martin B. Leon, MD
7:30 PM REALITY Head-To-Head Comparison Alexandre Abizaid, MD
7:50 PM Safety and Efficacy of Cypher on Complex Lesion Seung-Jung Park, MD
8:10 PM Is Sirolimus Different from Analogues? Robert Falotico, MD
8:30 PM Discussion and Q&A  
     
 
Friday | April 29, 2005

Main Arena
Vista Hall, W-Hotel, Level B2
8:30 AM~6:00 PM

Live Case Session 2
Columbia University Medical Center, New York, USA
Moderators: Martin B. Leon, MD, Gregg W. Stone, MD
8:30 AM
Discussants:
Alexandre Abizaid, MD
Ted Feldman, MD
Kyoo-Rok Han, MD
Kwon-Bae Kim, MD
Michael Kang-Yin Lee, MD
Yean-Leng Lim, MD
Gary S. Mintz, MD
Seong-Wook Park, MD
Seung-Jung Park, MD
Hideo Tamai, MD
   
State-of-the-Art Lectures 1
Moderator: Dong Joo Oh, MD
10:00 AM Percutaneous Heart Valve Therapy
Martin B. Leon, MD
10:15 AM Virtual Histology - A Technical and Clinical Update Gary S. Mintz, MD
 
Live Case Session 3
The Catholic University, St. Mary's Hospital, Seoul, Korea
Asan Medical Center, Seoul, Korea : Cases #3, #4, #5
Moderators: Ted Feldman, MD, Seong-Wook Park, MD
10:30 AM
Discussants:
Anthony Fung, MD
Mun Kyung Hong, MD
Man-Hong Jim, MD
Duk-Kyung Kim, MD
Jeong Hyun Kim, MD
Richard E. Kuntz, MD
Richard Ng, MD
John Ormiston, MD
Keum Soo Park, MD
Shigeru Saito, MD
     
State-of-the-Art Lectures 2
Moderator: Young-Bae Park, MD
12:00 PM What Are the Clinical Gaps and Unanswered Questions for DES in 2005 ? David R. Holmes, Jr, MD
12:15 PM Pathology of Vulnerable Plaque Renu Virmani, MD
     
12:30 PM Lunchtime Activities  
   
Live Case Session 4
Cardiovascular Institute & Fu Wai Hospital, Beijing, China
Asan Medical Center, Seoul, Korea : Cases #6, #7, #8
Moderators: Seung-Jung Park, MD, Junbo Ge, MD
2:00 PM
Discussants:
Chi Kin Chan, MD
Yong Huo, MD
Ik-Kyung Jang, MD
Myung-Ho Jeong, MD
Kee-Sik Kim, MD
Takeshi Kimura, MD
Raj R. Makkar, MD
Ian T. Meredith, MD
Shih-Pu Wang, MD
     
State-of-the-Art Lectures 3
Moderator: Won-Heum Shim, MD
3:30 PM Peripheral Vascular Interventions: What Is Possible in 2005 ? Gerald Dorros, MD
3:45 PM Renal Stenting: ASPIRE II , Update on Resist and CORAL Trial Status Krishna Rocha-Singh, MD
   
Live Case Session 5
San Raffaele Hospital, Milano, Italy
Moderators: Gregg W. Stone, MD, Jean Fajadet, MD
4:00 PM
Discussants:
Paul Chen, MD
David R. Holmes, Jr, MD
I Chang Hsieh, MD
Chong-Jin Kim, MD
Young Dae Kim, MD
Meilin Liu, MD
Gary S. Mintz, MD
Seung-Jung Park, MD
Takehiro Yamashita, MD
Shu Yang Zhang, MD
5:40 PM Featured Lecture : A Brief Status Update on REALITY (CYPHER vs TAXUS in Complex Lesions) Antonio Colombo, MD
     
6:00 PM Adjourn  
Tutorial Auditorium (How to - What to)
Mugunghwa Hall 1, Sheraton Grande Walkerhill Seoul Hotel, Level 1
11:00 AM ~ 6:30 PM
State of the Art Lectures 1
Moderator: Byung-Hee Oh, MD
11:00 AM
The Innovation Revolution: Next Generation DES Systems Martin B. Leon, MD
11:15 AM Advanced Tips, Tricks, and Philosophies for Approaching Difficult Lesions - A Japanese Perspective Hideo Tamai, MD
   
Live Case Session 1
The Catholic University of Korea, St. Mary's Hospital, Seoul, Korea
Moderators: Martin B. Leon, MD, Hideo Tamai, MD
11:30 AM
Discussants:
Young-Keun Ahn, MD
In-Ho Chae, MD
Jei Kun Chai, MD
Sameer Indravadan Dani, MD
Gerald Dorros, MD
Shu Kin Li, MD
Sunao Nakamura, MD
Mitsuyasu Terashima, MD
     
12:30 PM Lunchtime Activities  
     
State of the Art Lectures 2
Moderator: Eak-Kyun Shin, MD
2:00 PM SFA Interventions (Including New Technique, CTO) Krishna Rocha-Singh, MD
2:15 PM The E-valve Edge-to-Edge Repair for Mitral Regurgitation: Design Concept and EVEREST Update Ted Feldman, MD
2:30 PM Carotid Stenting With Protection Devices Paul Hsien-Li Kao, MD
   
Live Case Session 2
Cardiovascular Institute & Fu Wai Hospital, Beijing, China
Moderators: Jilin Chen, MD, Ki Bae Seung, MD
3:00 PM
Discussants:
Latchumana Dhas, MD
Ted Feldman, MD
Mujeeb-Ul-Haq, MD
Upendra Kaul, MD
Sang Hoon Lee, MD
Swee Choon Ng, MD
Jeong Euy Park, MD
Alan C. Yeung, MD
   
Vulnerable Plaque; How to detect, How to treat
4:00 PM~6:30 PM
Moderators: Ik-Kyung Jang, MD, Richard E. Kuntz, MD
4:00 PM Erosion, Intraplaque Hemorrhage: The Other Face of Vulnerability Renu Virmani, MD
4:15 PM Characterization of Coronary Atherosclerotic Plaques Using CTA Koen Nieman, MD
4:30 PM Structural and Molecular Magnetic Resonance Imaging of High-Risk Atherosclerosis Farouc Jaffer, MD
4:45 PM Imaging Inflamed Atherosclerotic Plaques with Positron Emission Tomography Ahmed Tawakol, MD
5:00 PM Coronary Artery Thermography Christodoulos Stefanadis, MD
5:15 PM Detection and Treatment of Thin Fibrous Cap, Lipid Rich, and Inflammatory Vulnerable Plaque - Angioscopic Evaluation Kyoichi Mizuno, MD
5:30 PM Intravascular Imaging Modalities for Detection of Vulnerable Plaque: IVUS, MR, and OCT Ik-Kyung Jang, MD
5:45 PM Epidemiologic Stent-Based Approach to Vulnerable Plaque Stabilization Based on Statistical Modeling of Plaque Rupture and Death Richard E. Kuntz, MD
6:00 PM Regional Photodynamic Therapy for Vulnerable Plaque Stabilization I: Antrin Alan C. Yeung, MD
6:15 PM Preventing and Arresting Atherosclerosis; Preventing and Arresting Coronary Atherosclerosis William C. Roberts, MD
   
6:30 PM Adjourn
 
Breakfast Meetings
Meet the Experts: Mini-Lectures and Case Discussions

Sheraton Grande Walkerhill Hotel
7:00 AM-8:30 AM
#1. Bifurcation Lesions
Art Room, Level 4
Moderators: John Ormiston, MD, Junbo Ge, MD
7:00 AM Bench Insights into Bifurcation Stenting Strategies. An Update John Ormiston, MD
7:10 AM Efficacy of FX Minirail Balloon in Bifurcation Lesions Junbo Ge, MD
7:20 AM PCI for Bifurcation in LMT Takahiko Suzuki, MD
7:30 AM
Case Presentations:
Seung-Whan Lee, MD
Deuk-Young Nah, MD
Naoto Inoue, MD
   
#2. Drug Eluting Stent Summit - II
Tutorial Auditorium, Level 1
Moderators: Eberhard Grube, MD, Yean-Teng Lim, MD
7:00 AM DES for Bifurcation Lesion Yean-Teng Lim, MD
7:10 AM Final QCA and 3D-IVUS Results From a FIM Experience Using an Angiopeptin PC-Coated Stent Vincent On-Hing Kwok, MD
7:20 AM DES for Complex Patients Subsets Alexandre Abizaid, MD
7:30 AM Everolimus Drug-Eluting Stents I: Review of Guidant FUTURE I and II, and Status Update of FUTURE III and IV Eberhard Grube, MD
7:40 AM ZoMaxx: Abbott's Drug Eluting Stent Program John Ormiston, MD
7:50 AM
Case Presentations:
Hyun Sook Kim, MD
Young Joon Hong, MD
   
#3. Acute Myocardial Infarction
Cosmos Room, Level 3
Moderators: Gregg W. Stone, MD, Toshiya Muramatsu, MD
7:00 AM EMERALD Trial: Lessons Learned Gregg W. Stone, MD
7:10 AM Final Results of ASPARAGAS Study Toshiya Muramatsu, MD
7:20 AM Coronary Flow Pattern and Myocardial Viability: Comparison with PET Seung-Jea Tahk, MD
7:30 AM Does Distal Protection?Reduce Infarct Size During Primary Angioplasty?: MRI Study Hyeon-Cheol Gwon, MD
7:40 AM Multivessel versus Single-vessel Angioplasty During Acute MI Mun Kyung Hong, MD
7:50 AM
Case Presentations:
Young-Keun Ahn, MD
Takehiro Yamashita, MD
   
#4. Chronic Total Occlusions
Mugunghwa Room 4, Level 1
Moderators: James R. Margolis, MD, Kazuaki Mitsudo, MD
7:00 AM IVUS Guided Wire Crossing for CTO Takahiko Suzuki, MD
7:10 AM PCI for CTO Kazuaki Mitsudo, MD
7:20 AM Coated vs Non-Coated Wires for CTO James R. Margolis, MD
7:30 AM Long Term Result of Cypher Stenting in CTO Hweung Kon Hwang, MD
7:40 AM
Case Presentations:
Nakul Sinha, MD
Yi-Heng Li, MD
Joy M Thomas, MD
   
#5. Complex PCI
Calla Room, Level 1
Moderators: Kenneth Chin, MD, Ki Bae Seung, MD
7:00 AM Drug Eluting Stents in Ostial Lesions Kenneth Chin, MD
7:15 AM Cypher - LAD Ostial Lesions; No More Surgery ! Ki Bae Seung, MD
7:30 AM
Case Presentations:
Pramod Jaiswal, MD
Anil Dhall , MD
   
Lunchtime Activities
Sheraton Grande Walkerhill Seoul Hotel
12:30 PM-2:00 PM
#1. Angiomygenesis
Calla Room, Level 1
Sponsored by Clinical Research Center for Ischemic Heart disease, The Korea Ministry of Health and Welfare
Moderator: Hyo-Soo Kim, MD
12:30 PM Opening Remark Hyo-Soo Kim, MD
12:35 PM Stem Cell Biology for Vasculogenesis Takayuki Asahara, MD
1:00 PM Novel Modulators of Progenitor Cell Mobilization Kenneth Walsh, MD
1:25 PM Angiogenesis Mediated by Adipose-Derived Stromal Cells: How Fat Can Be Good Keith L. March, MD
1:50 PM Q&A  
 
#2. Current Standards and Proposed Directions in Pharmacologic Approaches for PCI
Tutorial Auditorium, Level 1
Sponsored by Bristol-Myers Squibb Company
Moderators: Gregg W Stone, MD, Seung-Jea Tahk, MD
12:30 PM Opening Remark  
12:40 PM Metabolic Syndrome, Acute Coronary Syndrome and Adipocytokines / Q&A Tohru Funahashi, MD
1:00 PM Facilitated PCI in AMI Seung-Jea Tahk, MD
1:20 PM Optimizing Outcomes of Primary PCI: From CADILLAC to HORIZONS Gregg W. Stone, MD
1:40 PM Closing Remark  
   
#3. Lipid Management : A New Era in The Treatment of Coronary Artery Disease
Mugunghwa Room 4, Level 1
Sponsored by Pfizer Pharmaceuticals Korea Ltd.
Moderator: Wook-Sung Chung, MD
12:30 PM Welcome Address Wook-Sung Chung, MD
12:40 PM The TNT Trial: Is It Time to Shift Our Goals in Clinical Practice David Colquhoun, MD
1:00 PM Early Statin Therapy in Acute Coronary Syndrome Cheol-Whan Lee, MD
1:20 PM Beyond the Statin Therapy: The Importance of HDL Cholesterol Ki Hoon Han, MD
1:40 PM Q & A  
   
#4. Drug Eluting Stent Summit - III
Cosmos Room, Level 3
Sponsored by CVRF
Moderators: Gian Battista Danzi, MD, Seong-Wook Park, MD
12:30 PM Update on Jupiter?and? Clinical Trials with the Sorin Carbostent Tacrocimus Eluting Stent Gian Battista Danzi, MD
12:45 PM Drug-Eluting Biodegradable Igaki-Tamai Stent Hideo Tamai, MD
1:00 PM Update on the Endeavor I-V Trials:?The Latest Results Ian T. Meredith, MD
1:15 PM Terumo DES Program -Nobori 1 Clinical Trial- Hidehiko Honda, MD
   
#5. “Reducing Cardiovascular Risk” – Keyword in Managing Hypertension and Lipid
Art Room, Level 4
Sponsored by MSD KOREA LTD.
Moderator: William C. Roberts, MD
12:30 PM Welcome Address  
12:40 PM Mechanisms Linking Angiotensin II & Atherogenesis Carlos M. Ferrario, MD
1:00 PM The Rationale for Angiotensin II Receptor Blockers (ARBs) in Human Hypertension: Based on Correction of Arterial Remodeling and Endothelial Dysfunction Jeong Bae Park, MD
1:20 PM Reducing Cardiovascular Risk Through Intensive Lipid Lowering Therapy: Lower is Better Through Dual Inhibition William C. Roberts, MD
1:40 PM Q & A  
     
 
Saturday | April 30, 2005
Main Arena
Vista Hall, W-Hotel, Level B2
8:30 AM~3:45 PM
Live Case Session 6
Toyohashi Heart Center, Aichi, Japan
Asan Medical Center, Seoul, Korea : Cases #9, #10, #11
Pusan National University Hospital, Pusan, Korea
Moderators: Martin B. Leon, MD, Hideo Tamai, MD
8:30 AM
Discussants:
Yaron Almagor, MD
Wook-Sung Chung, MD
Luyue Gai, MD
Moo Hyun Kim, MD
Tian-Hai Koh, MD
Kenneth Ka-Hing Lam, MD
James R. Margolis, MD
Chiung-Jen Wu, MD
Junghan Yoon, MD
 
 
State-of-the-Art Lectures 4
Moderator: Seung-Jung Park, MD
10:30 AM Evidence-Based Medicine Analysis of Current DES Clinical Use Guidelines: A Roadmap for Clinicians Gregg W. Stone, MD
10:45 AM Plaque Progression and Regression James R. Margolis, MD
   
Live Case Session 7
Asan Medical Center, Seoul, Korea : Cases #12, #13, #14
Moderators: David R. Holmes, MD, Krishna Rocha-Singh, MD
11:00 AM
Discussants:
Chien-Ming Huang, MD
Young Jo Kim, MD
Seung-Hwan Lee, MD
Kazuaki Mitsudo, MD
S.S. Ramesh, MD
Mohd Ali Rosli, MD
Won-Heum Shim, MD
Udayachalerm Wasan, MD
Tetsu Yamaguchi, MD
     
State-of-the-Art Lectures 5
Moderator: Dong Joo Oh, MD
12:00 PM What Are the Proper End Points for DES